Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults Projection Based on the CSPPT

The CSPPT (China Stroke Primary Prevention Trial) demonstrated a significant risk reduction of first stroke in hypertensive patients treated with enalapril plus folic acid compared with those with enalapril alone, but the lifetime stroke-free survival associated with the treatment is unknown. By est...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Hypertension
Glavni autori: Zhang, Tiantian, Lin, Tengfei, Wang, Yang, Wang, Binyan, Qin, Xianhui, Xie, Feng, Cui, Yimin, Huo, Yong, Wang, Xiaobin, Zhang, Zugui, Jiang, Jie
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8020900/
https://ncbi.nlm.nih.gov/pubmed/31865785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14102
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items